NORTHERN TRUST CORP - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 36 filers reported holding NRX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$19,499
-46.2%
74,9960.0%0.00%
Q2 2023$36,261
-22.8%
74,996
+5.3%
0.00%
Q1 2023$46,955
-27.8%
71,241
+21.6%
0.00%
Q4 2022$65,044
+51.3%
58,5980.0%0.00%
Q3 2022$43,000
+22.9%
58,5980.0%0.00%
Q2 2022$35,000
-75.7%
58,5980.0%0.00%
Q1 2022$144,000
-16.8%
58,598
+61.5%
0.00%
Q4 2021$173,000
-88.6%
36,276
-72.2%
0.00%
Q2 2021$1,518,000130,6330.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 325,000$84,5000.06%
Texas Capital Bank Wealth Management Services Inc 63,290$16,4550.00%
XTX Topco Ltd 11,809$3,0700.00%
United Asset Strategies, Inc. 18,300$4,7580.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 160,700$41,7820.00%
UBS Group AG 1,210$3150.00%
NewEdge Advisors, LLC 7,125$1,8530.00%
Lido Advisors, LLC 13,000$3,3800.00%
OSAIC HOLDINGS, INC. 11,125$2,8910.00%
WELLS FARGO & COMPANY/MN 5,379$1,3990.00%
View complete list of NRX PHARMACEUTICALS INC shareholders